Aspirin alone versus two blood thinners after heart bypass
Treatments studied
Part of Heart & circulation clinical trials.
This Phase 3 trial compares two strategies to prevent blood clots after heart bypass surgery: aspirin alone versus aspirin plus ticagrelor. It aims to see which approach works better and is safer for people whose bypass does not fully restore blood flow.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for heart bypass surgery (CABG) with or without a heart-lung machine or other heart procedures
- Your surgeons believe your blood-flow repair is incomplete after the bypass (not fully reconnected or not fully effective)
- You can give informed consent for the study
- You are not currently taking two blood thinners (dual antiplatelet therapy) when admitted to the hospital
- You can safely take aspirin and ticagrelor (no known intolerance or inability to take them)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different lengths of time for taking a blood thinner after heart bypass surgery to see which is safer and works better. It may help reduce the risk of blood clots or bleeding after surgery.
This study follows patients who had a first-time heart bypass operation (CABG) to see how a blood-thinning medicine called ticagrelor affects their recovery and long-term health. It may help doctors understand the best way to prevent complications after surgery.
This trial compares two common “blood thinner” combinations to prevent problems after a PCI procedure for complex blocked heart arteries. It may help your care team find which combination works better for people with higher-risk artery patterns.
This trial tests if people who have been on two blood thinners (aspirin plus prasugrel or ticagrelor) for at least 90 days after getting a heart stent can safely switch to just one of those blood thinners. It aims to see if taking only one pill is as safe and effective as taking two.
This trial tests whether taking just one blood thinner (clopidogrel) is as safe and effective as taking two (clopidogrel plus aspirin) for older adults or people at high bleeding risk who have had a drug-coated balloon procedure to open blocked heart arteries.
This study compares two ways to lower the chances of another heart attack: taking the standard medicine (clopidogrel) versus taking a combination of aspirin and a lower dose of a blood thinner (rivaroxaban). If you join, you'll be assigned to one of these options to see which works better for people like you.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.